1. Home
  2. CDE vs ENOV Comparison

CDE vs ENOV Comparison

Compare CDE & ENOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Coeur Mining Inc.

CDE

Coeur Mining Inc.

HOLD

Current Price

$19.25

Market Cap

13.5B

ML Signal

HOLD

Logo Enovis Corporation

ENOV

Enovis Corporation

HOLD

Current Price

$23.76

Market Cap

1.4B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CDE
ENOV
Founded
1928
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Precious Metals
Fluid Controls
Sector
Basic Materials
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
13.5B
1.4B
IPO Year
1994
2008

Fundamental Metrics

Financial Performance
Metric
CDE
ENOV
Price
$19.25
$23.76
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
9
Target Price
$22.40
$47.38
AVG Volume (30 Days)
20.3M
683.7K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
533.33
N/A
EPS
0.95
N/A
Revenue
$709,598,000.00
N/A
Revenue This Year
$165.39
$6.36
Revenue Next Year
$12.10
$5.31
P/E Ratio
$19.72
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.21
$21.00
52 Week High
$27.77
$36.82

Technical Indicators

Market Signals
Indicator
CDE
ENOV
Relative Strength Index (RSI) 47.34 49.55
Support Level $19.08 $21.37
Resistance Level $19.73 $26.72
Average True Range (ATR) 0.92 1.19
MACD 0.05 -0.11
Stochastic Oscillator 29.69 34.90

Price Performance

Historical Comparison
CDE
ENOV

About CDE Coeur Mining Inc.

Coeur Mining Inc is a metals producer focused on mining precious minerals in the Americas. It is involved in the discovery and mining of gold and silver and generates the vast majority of revenue from the sale of these precious metals. The operating mines of the company are palmarejo, Rochester, Wharf, and Kensington. Its projects are located in the United States, Canada, and Mexico generating maximum revenue from United States.

About ENOV Enovis Corporation

Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.

Share on Social Networks: